ArticleNature communications2022

Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate.

Kwinten Sliepen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.